title: Production of insulin-like growth factor-II by human fetal pancreas in culture.
abstract: Insulin-like growth factor-II (IGF-II) is a polypeptide hormone thought to be involved in fetal development because of its wide distribution in fetal tissues and its presence in the fetal circulation. We have developed a highly sensitive radioreceptor assay for IGF-II using rat liver microsomal membranes and have used this assay to test for the presence of IGF-II in the human fetal pancreas and the release of IGF-II by the human fetal pancreas in organ culture. IGF-II was present in extracts of pancreatic tissue (0.056 +/- 0.012 pmol/mg tissue, n = 5) and was released in culture at the rate of 0.027-0.134 pmol/mg tissue per day with release being maintained for at least 3 weeks in culture. The rate of release was not affected by the gestational age of the fetus over 14 to 20 weeks but was significantly related to the rate of insulin release (r = 0.712, P less than 0.001, n = 34). Chronic exposure to 12-0-tetradecanoylphorbol-13-acetate (TPA), which inhibits insulin release in the human fetal pancreas, caused an 85% drop in IGF-II production, which was reversed when TPA was removed. These studies demonstrate that IGF-II is produced by the human fetal pancreas in a pattern similar to that of insulin. We suggest that control of IGF-II release, like that of insulin, may involve protein-kinase C and that IGF-II may have a paracrine or autocrine role in the development of fetal pancreatic function.
authors.affiliation: Department of Medicine, University of Sydney, New South Wales, Australia.
authors.forename: J M
authors.initials: JM
authors.lastname: Bryson
authors.forename: B E
authors.initials: BE
authors.lastname: Tuch
authors.forename: R C
authors.initials: RC
authors.lastname: Baxter
mesh_terms: D005333:Fetus; D006801:Humans; D007328:Insulin / Q000378:metabolism; D000078790:Insulin Secretion; D007335:Insulin-Like Growth Factor II / Q000096:biosynthesis*; D009924:Organ Culture Techniques; D010179:Pancreas / Q000187:drug effects / Q000378:metabolism*; D013002:Somatomedins / Q000096:biosynthesis*; D013755:Tetradecanoylphorbol Acetate / Q000494:pharmacology; D013997:Time Factors
chemical_list: D007328:Insulin; D013002:Somatomedins; D007335:Insulin-Like Growth Factor II; D013755:Tetradecanoylphorbol Acetate